Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
High level of vaccine efficacy maintained over a 6-month period of surveillance
Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Subscribe To Our Newsletter & Stay Updated
